Patent details

EP1666057 Title: Method of manufacture of an acellular vaccine comprising Bordetella pertussis antigens

Basic Information

Publication number:
EP1666057
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP040183295
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Method of manufacture of an acellular vaccine comprising Bordetella pertussis antigens
French Title of Invention:
Procédé de production d'un vaccin acellulaire contenant des antigènes de Bordetella pertussis
German Title of Invention:
Verfahren zur Herstellung eines azellulären Impfstoffes der Bordetella pertussis Antigene enthält
SPC Number:
91595
91591
91594
91596
91592
91593
91597

Dates

Filing date:
26/04/1990
Grant date:
18/02/2009
EP Publication Date:
18/02/2009
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/06/2006
EP B1 Publication Date:
18/02/2009
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
26/04/2010
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
26/04/1990
 
 

Name:
MEDEVA B.V.
Address:
Churchilllaan 223, 1078 ED Amsterdam, Netherlands (NL)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
04/03/2009
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
Novotny Pavel
Address:
Netherlands (NL)

Priority

Priority Number:
8910570
Priority Date:
08/05/1989
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
A61K 39/10;
Filing date Document type Number of pages